Sign in
DMAAR Stock Price, Chart, Stats & News
Drugs Made In America Acquisition Corp. Rights
Save
Drugs Made In America Acquisition Corp. Rights (DMAAR) does not currently pay a dividend.
287.76M
Market cap
0.69x
Current P/E
–
Forward P/E
DMAAR chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | 2.41% |
ROE | 3.35% |
D/E | – |
Interest coverage ratio | – |
DMAAR valuation
P/E | 0.69x |
P/S | – |
P/B | 1.05x |
P/CF | -583.15x |
P/FCF | -849.80x |
P/OCF | -583.15x |
PEG | 688.04x |
EV multiple | -484.39x |
About
Drugs Made In America Acquisition Corp. (DMAAR) is a special purpose acquisition company (SPAC), established with the primary objective of identifying and acquiring one or more active businesses or their assets.
Similar securities
Based on sector and market capitalization
Report issue